Screening of Relevant Genes and Signalling Pathways Affecting Adult Urosepsis: A Bioinformatic Analysis
Urology Journal,
Vol. 22 No. 04 (2025),
8 October 2025
,
Page 203-208
https://doi.org/10.22037/uj.v22i.7933
Abstract
Purpose: The cellular and molecular pathophysiology of urosepsis, a condition caused by a urinary tract infection spreading to the bloodstream, involves complex epigenetic behavior. The objective of this study was to identify relevant genes and signaling pathways in adult urosepsis through a bioinformatic analysis of differentially expressed genes (DEGs).
Materials and Methods: In this in silico study, the GSE69528 dataset, containing 138 total RNA blood samples from patients with sepsis and uninfected controls, was obtained from the Gene Expression Omnibus (GEO) database. Microarray data were analyzed using GEO2R tools and R software. DEGs were identified using a fold change (FC) cutoff of > 1.5 or < 0.67 and a significance level of p < 0.05. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were used to determine the enriched pathways of DEGs before constructing protein-protein interaction (PPI) networks with STRING and Cytoscape.
Results: A total of 108 DEGs were identified, comprising 67 upregulated and 41 downregulated genes. GO and KEGG analyses revealed that these DEGs were significantly enriched in pathways such as the complement and coagulation cascade, neutrophil degranulation, negative regulation of interferon-gamma response, T-cell activation, and granulocyte differentiation. The PPI network analysis identified 67 nodes with 110 interactions, from which CEACAM8, MPO, and RETN were identified as hub genes. Overexpression of CEACAM8 and MPO and suppression of RETN may be associated with a better disease prognosis.
Conclusion: The identified hub genes—CEACAM8, MPO, and RETN—are predicted to be significant biomarkers in the prognosis and progression of sepsis. These genes could be targeted for the discovery of new therapeutic drugs for treating and managing urosepsis.
- Urosepsis, CEACAM 8, RETN, MPO, and GEO
How to Cite
References
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801-810.
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200-211.
Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20:5376.
Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.
Zhang YY, Ning BT. Signaling pathways and intervention therapies in sepsis. Signal Transduct Target Ther. 2021;6:407.
Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167-1174.
Mathias B, Szpila BE, Moore FA, Efron PA, Moldawer LL. A Review of GM-CSF Therapy in Sepsis. Medicine (Baltimore). 2015;94:e2044.
Chousterman BG, Arnaud M. Is There a Role for Hematopoietic Growth Factors During Sepsis? Front Immunol. 2018;9:1015.
Tau G, Rothman P. Biologic functions of the IFN-gamma receptors. Allergy. 1999;54:1233-1251.
Paudel S, Ghimire L, Jin L, Jeansonne D, Jeyaseelan S. Regulation of emergency granulopoiesis during infection. Front Immunol. 2022;13:961601.
Ashe A, Colot V, Oldroyd BP. How does epigenetics influence the course of evolution?. Philos Trans R Soc Lond B Biol Sci. 2021;376:20200111.
Binnie A, Tsang JL, Hu P, Carrasqueiro G, Castelo-Branco P, Dos Santos CC. Epigenetics of sepsis. Crit Care Med. 2020;48:745-756.
Binnie A, Walsh CJ, Hu P, et al. Epigenetic profiling in severe sepsis: a pilot study of DNA methylation profiles in critical illness. Crit Care Med. 2020;48:142-150.
Beltrán-García J, Casabó-Vallés G, Osca-Verdegal R, et al. Alterations in leukocyte DNA methylome are associated to immunosuppression in severe clinical phenotypes of septic patients. Front Immunol. 2024;14:1333705.
Cao L, Zhu T, Lang X, et al. Inhibiting DNA methylation improves survival in severe sepsis by regulating NF-κB pathway. Front Immunol. 2020;11:1360.
Han Q, Zhou H, Xie W, Sun T, Wei R, Nie C, Hong J, Zhu L, Tian W. Association between the methylation of the STAT1 and SOCS3 in peripheral blood and gastric cancer. J Gastroenterol Hepatol. 2020;35:1347-1354.
Chen F, Zou L, Williams B, Chao W. Targeting toll-like receptors in sepsis: from bench to clinical trials. Antioxid Redox Signal. 2021;35:1324-1339.
Futami Y, Takeda Y, Koba T, et al. Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles. Int Immunol. 2022;34:327-340.
Gabarin RS, Li M, Zimmel PA, Marshall JC, Li Y, Zhang H. Intracellular and extracellular lipopolysaccharide signaling in sepsis: avenues for novel therapeutic strategies. J Innate Immun. 2021;13:323-332.
Benahmed D, Abbadi M, Zaoui D, et al. Tumor necrosis factor alpha induced protein 3, interleukin 10, tumor necrosis factor alpha, and interleukin 17 F genes polymorphisms in Algerian patients with rheumatoid arthritis. Mol Biol Rep. 2024;51:545.
Li J, He Y, Li Y. Tumor Necrosis Factor, α-Induced Protein 3 Interacting Protein 2 is Involved in the Inflammatory Response in Sepsis via Inhibiting the Nuclear Factor-κB Pathway Activation. J Biomater Tiss Eng. 2020;10:582-588.
Choi H, Lee JY, Yoo H, Jeon K. Bioinformatics analysis of gene expression profiles for diagnosing sepsis and risk prediction in patients with sepsis. Int J Mol Sci. 2023;24:9362.
Liu Z, Qiu E, Yang B, Zeng Y. Uncovering hub genes in sepsis through bioinformatics analysis. Medicine (Baltimore). 2023;102:e36237.
Jiang Z, Luo Y, Wei L, et al. Bioinformatic analysis and machine learning methods in neonatal sepsis: identification of biomarkers and immune infiltration. Biomedicines. 2023;11:1853.
Shi S, Pan X, Zhang L, et al. An application based on bioinformatics and machine learning for risk prediction of sepsis at first clinical presentation using transcriptomic data. Front Genet. 2022;13:979529.
Liang G, Li J, Pu S, He Z. Screening of sepsis biomarkers based on bioinformatics data analysis. J Healthc Eng. 2022;2022:6788569.
Zeng X, Feng J, Yang Y, et al. Screening of key genes of sepsis and septic shock using bioinformatics analysis. J Inflamm Res. 2021:829-841.
Yu R, Wang Y, Liang Q, Xu Y, Yusf AE, Sun L. Identification of potential biomarkers and pathways for sepsis using RNA sequencing technology and bioinformatic analysis. Heliyon. 2023;9.
Wu J, Cao X, Huang L, Quan Y. Construction of a NETosis-related gene signature for predicting the prognostic status of sepsis patients. Heliyon. 2024;10.
Ribon M, Mussard J, Semerano L, Singer BB, Decker P. Extracellular chromatin triggers release of soluble CEACAM8 upon activation of neutrophils. Front Immunol. 2019;10:1346.
Lu J, Li Q, Wu Z, et al. Two gene set variation indexes as potential diagnostic tool for sepsis. Am J Transl Res. 2020;12:2749.
- Abstract Viewed: 388 times
- 7933/pdf Downloaded: 178 times